Karim Fizazi
0000-0002-6068-9474
Publication & Citation Trends
Publications
0 total
[Living with… testicular cancer].
Cited by 0
Semantic Scholar
Redefining Good-prognosis Seminoma: Implications for Clinical Practice of the Updated International Germ Cell Cancer Collaborative Group Classification and Results from the SEMITrends Survey.
Cited by 0
Semantic Scholar
P215 SEMITrends: a global survey on the impact of the updated IGCCCG prognostic classification in the real-life management trends of testicular seminomatous germ cell tumours OA
Cited by 1
Semantic Scholar
Patterns of relapse in poor-prognosis germ-cell tumours in the GETUG 13 trial: Implications for assessment of brain metastases.
Cited by 20
Semantic Scholar
Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumors. OA
Cited by 25
Semantic Scholar
Testicular non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. OA
Cited by 15
Semantic Scholar
Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours OA
Cited by 33
Semantic Scholar
Research Topics
Prostate Cancer Treatment and Research
(1064)
Radiopharmaceutical Chemistry and Applications
(397)
Cancer, Lipids, and Metabolism
(269)
Cancer Genomics and Diagnostics
(201)
Prostate Cancer Diagnosis and Treatment
(188)
Affiliations
Université Claude Bernard Lyon 1
Université Paris-Sud
AstraZeneca (United Kingdom)
University of North Carolina at Chapel Hill
Hebron University